Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-014091
Filing Date
2024-02-12
Accepted
2024-02-12 14:00:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A tm244399-4_s3a.htm S-3/A 104204
2 EXHIBIT 5.1 tm244399d5_ex5-1.htm EX-5.1 25743
3 GRAPHIC tm244399d5_ex5-1img02.jpg GRAPHIC 4753
4 GRAPHIC tm244399d5_ex5-1img01.jpg GRAPHIC 2405
  Complete submission text file 0001104659-24-014091.txt   141224
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-276814 | Film No.: 24619043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)